On this page
Wilate
von Willebrand Factor/Coagulation Factor VIII Complex (Human)
351(a) Standalone BLA
Overview
Source: Purple BookProprietary name
Wilate
Proper name
von Willebrand Factor/Coagulation Factor VIII Complex (Human)
Licence type
351(a)
BLA number
125251
Applicant
Octapharma Pharmazeutika Produktionsges.m.b.H.
Center
CBER
Presentations
2
First licensure
—
Presentations
Source: Purple Book| Strength | Dosage form | Route | Presentation | Status | Licensed |
|---|---|---|---|---|---|
| 1000IU | For Injection | Intravenous | Single-Dose Vial | Rx | December 20, 2010 |
| 500IU | For Injection | Intravenous | Single-Dose Vial | Rx | December 20, 2010 |
Exclusivity
Source: Purple Book| Kind | Expires |
|---|---|
| Orphan exclusivity | December 1, 2030 |
Sources for this page
| Purple Book | FDA | Licence type, presentations, reference product, exclusivity |